asset backed digital currency, Featured snippets

Shenzhen reports an explosion in a residential building: fire rescue forces have arrived, and Shenzhen Fire Release Report: At 14: 46 on December 11, 2024, Shenzhen Fire Rescue Detachment received an alarm: an alarm occurred in Yuefu Phase II Building, Yuehai Street, Nanshan District, and the command center dispatched 16 fire engines and 80 fire rescue personnel from the first battle force to the scene for disposal, and the full-time command group of Nanshan Brigade was dispatched. At present, fire rescue forces have arrived, and the specific situation needs further verification.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.Market News: The Knesset group approved a bill to increase deficit ratio's GDP to 7.7%, which will be submitted to the Knesset plenary session for voting.

Hangzhou supports local enterprises to strive for tax-free licenses. Hangzhou Jiebai responded: The relevant policies have long existed, and there is an opportunity to fight for them. Hangzhou Jiebai has a daily limit in the afternoon. In the news, the "Three-year Action Plan for Hangzhou to Build a City of Games and Stay Night in Hangzhou" (2025-2027) is open for comments. It is mentioned that it is proposed to support tax-free and tax-refund consumption in the city. Encourage qualified duty-free goods operators to set up duty-free shops in Hangzhou, and support Hangzhou enterprises to strive for duty-free licenses. In this regard, the reporter contacted the investor relations department of Hangzhou Jiebai as an investor. Relevant persons said that the relevant policies have existed for a long time, and said that "so far (Hangzhou) has only one (with a tax-free license)" For the tax-free license, the person said that the opportunity will be won. (21 Finance)Hualu Hengsheng: The adipic acid plant of nylon 66 high-end new material project was put into production. Hualu Hengsheng (600426) announced on the evening of December 11th that the adipic acid plant of the company's nylon 66 high-end new material project had been put through the process, produced qualified products and entered the trial production stage. Production facilities such as nylon 66 are currently under construction. After the adipic acid plant is put into production, 200,000 tons/year of adipic acid can be added, which lays a foundation for the company to further expand the new chemical materials sector and is conducive to improving the comprehensive competitiveness of enterprises.Hangzhou supports local enterprises to strive for tax-free licenses. Hangzhou Jiebai responded: The relevant policies have long existed, and there is an opportunity to fight for them. Hangzhou Jiebai has a daily limit in the afternoon. In the news, the "Three-year Action Plan for Hangzhou to Build a City of Games and Stay Night in Hangzhou" (2025-2027) is open for comments. It is mentioned that it is proposed to support tax-free and tax-refund consumption in the city. Encourage qualified duty-free goods operators to set up duty-free shops in Hangzhou, and support Hangzhou enterprises to strive for duty-free licenses. In this regard, the reporter contacted the investor relations department of Hangzhou Jiebai as an investor. Relevant persons said that the relevant policies have existed for a long time, and said that "so far (Hangzhou) has only one (with a tax-free license)" For the tax-free license, the person said that the opportunity will be won. (21 Finance)

On the 11th, alumina fell by 3.61%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract alumina 2502 closed, with a volume of 174,600 lots. The position data showed that the top 20 seats were net, and the difference position was 10,936 lots. The total turnover of alumina futures contracts was 452,500 lots, an increase of 77,000 lots over the previous day. The first 20 seats in the contract held 264,800 lots, a decrease of 4,558 lots from the previous day. The short positions in the top 20 seats of the contract were 215,500 lots, a decrease of 1,290 lots from the previous day. (Sina Futures)The Taiwan Affairs Office of the State Council introduced the annual meeting of the 2024 Cross-Strait Entrepreneur Summit. Zhu Fenglian, a spokesperson for the Taiwan Affairs Office, said that the 2024 Cross-Strait Entrepreneur Summit was successfully held in Xiamen, Fujian from December 9 to 10. More than 700 business people from both sides of the Taiwan Strait attended the annual summit. Focusing on the theme of "Building a new era industrial chain across the Taiwan Strait to promote cross-strait economic integration and development", they conducted in-depth discussions on issues such as promoting cross-strait industrial Internet innovation, building Taiwanese enterprises to land in their first homes, and innovating cross-strait financial service systems. The exchange atmosphere was warm, which fully demonstrated the common aspiration of cross-strait industries to strengthen exchanges and cooperation. (Riyue Tan Tian)Bank of America: restore coverage to AbbVie, give it a "neutral" rating, and target price is $191.